198 related articles for article (PubMed ID: 12122741)
1. Hepatobiliary disease in inflammatory bowel disease.
Ahmad J; Slivka A
Gastroenterol Clin North Am; 2002 Mar; 31(1):329-45. PubMed ID: 12122741
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary manifestations of inflammatory bowel disease.
Raj V; Lichtenstein DR
Gastroenterol Clin North Am; 1999 Jun; 28(2):491-513. PubMed ID: 10372279
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
[TBL] [Abstract][Full Text] [Related]
4. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
Navaneethan U; Shen B
Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712
[TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis: a clinical update.
Williamson KD; Chapman RW
Br Med Bull; 2015 Jun; 114(1):53-64. PubMed ID: 25981516
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary complications of inflammatory bowel disease.
Lichtenstein DR
Curr Gastroenterol Rep; 2011 Oct; 13(5):495-505. PubMed ID: 21773706
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Complications of Inflammatory Bowel Disease.
Mahfouz M; Martin P; Carrion AF
Clin Liver Dis; 2019 May; 23(2):191-208. PubMed ID: 30947871
[TBL] [Abstract][Full Text] [Related]
8. PSC, AIH and overlap syndrome in inflammatory bowel disease.
Trivedi PJ; Chapman RW
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):420-36. PubMed ID: 22306055
[TBL] [Abstract][Full Text] [Related]
9. [Hepatobiliary manifestations in inflammatory bowel disease].
Solís Herruzo JA; Solís-Muñoz P
Rev Esp Enferm Dig; 2007 Sep; 99(9):525-42. PubMed ID: 18052648
[No Abstract] [Full Text] [Related]
10. Pancreatic and biliary tract disorders in inflammatory bowel disease.
Huang C; Lichtenstein DR
Gastrointest Endosc Clin N Am; 2002 Jul; 12(3):535-59. PubMed ID: 12486943
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary disease in inflammatory bowel disease.
Balan V; LaRusso NF
Gastroenterol Clin North Am; 1995 Sep; 24(3):647-69. PubMed ID: 8809241
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.
Heikius B; Niemelä S; Lehtola J; Karttunen T; Lähde S
Scand J Gastroenterol; 1997 Feb; 32(2):153-61. PubMed ID: 9051876
[TBL] [Abstract][Full Text] [Related]
13. [Cholestatic liver diseases].
Grimm D; Thimme R
Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and clinical spectrum of primary sclerosing cholangitis.
Gidwaney NG; Pawa S; Das KM
World J Gastroenterol; 2017 Apr; 23(14):2459-2469. PubMed ID: 28465630
[TBL] [Abstract][Full Text] [Related]
15. Hepatic manifestations of gastrointestinal diseases. Inflammatory bowel disease, celiac disease, and Whipple's disease.
Smyth C; Kelleher D; Keeling PW
Clin Liver Dis; 2002 Nov; 6(4):1013-32. PubMed ID: 12516204
[TBL] [Abstract][Full Text] [Related]
16. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
[TBL] [Abstract][Full Text] [Related]
17. Hepatic manifestations of inflammatory bowel diseases.
Restellini S; Chazouillères O; Frossard JL
Liver Int; 2017 Apr; 37(4):475-489. PubMed ID: 27712010
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis.
Williamson KD; Chapman RW
Dig Dis; 2014; 32(4):438-45. PubMed ID: 24969292
[TBL] [Abstract][Full Text] [Related]
19. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
Bergquist A; Glaumann H; Persson B; Broomé U
Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]